KEGG   DRUG: Dasiglucagon hydrochloride
Entry
D12314                      Drug                                   
Name
Dasiglucagon hydrochloride;
Zegalogue (TN)
Product
ZEGALOGUE (Novo Nordisk), ZEGALOGUE (Zealand Pharma US)
Formula
C152H222N38O50. xHCl
Remark
ATC code: H04AA02
Chemical structure group: DG03173
Product (DG03173): D12314<US>
Efficacy
Antidiabetic, Antihypoglycemia, Glucagon receptor agonist
  Disease
Diabetes mellitus [DS:H00408 H00409]
Comment
Glucagon analogue
Treatment of hypoglycemia in type 1 and type 2 diabetes patients
Target
GCGR [HSA:2642] [KO:K04583]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04922  Glucagon signaling pathway
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
  H04 PANCREATIC HORMONES
   H04A GLYCOGENOLYTIC HORMONES
    H04AA Glycogenolytic hormones
     H04AA02 Dasiglucagon
      D12314  Dasiglucagon hydrochloride <US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Glycemic Agents
   Dasiglucagon
    D12314  Dasiglucagon hydrochloride
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Glucagon
    GCGR
     D12314  Dasiglucagon hydrochloride <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12314
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D12314
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12314
Other DBs
PubChem: 497620727
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system